|
20.11.2024 15:06:06
|
Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM Sensor
(RTTNews) - Insulet Corp. (PODD), a provider of tubeless insulin pump technology, announced Wednesday that the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott Laboratories' (ABT) FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S.
This makes Omnipod 5 the most connected tubeless AID system in the U.S. As the number one prescribed and number one favorite pump in the U.S., the waterproof, discreet, and wearable Omnipod 5 is the first tubeless AID system that communicates with a CGM, proactively correcting for highs and helping to protect against lows, day and night.
The Omnipod 5 System simplifies diabetes management and has shown to improve results by eliminating the need for multiple daily injections (MDI) therapy and automatically adjusting insulin delivery every five minutes using its advanced SmartAdjust technology.
Nachrichten zu Abbott Laboratories
Analysen zu Abbott Laboratories
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
NEU✅ Wolters Kluwer
NEU✅ American Express
NEU✅ Deckers Outdoor
inklusive Rebalancing:
❌ Synopsys
❌ Vertex Pharmaceuticals Inc
❌ Targa Resources
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| Abbott Laboratories | 93.50 | -2.60% |
|
| Insulet Corp Shs | 175.82 | -37.18% |
|
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Nach US-Arbeitsmarktdaten: SMI und DAX gehen mit Abschlägen ins Wochenende -- US-Börsen verloren -- Asiens Börsen schliessen in RotDer heimische sowie der deutsche Aktienmarkt notierten zum Wochenende tiefer. Die US-Börsen präsentierten sich vor dem Wochenende tiefrot. In Asien zog es die Börsen am Freitag ins Minus.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |